Because cancer cells must transfer glucose into the pentose phosphate pathway to maintain their rapid growth, blocking the direct regulation of HK1 by KRAS4A is a potentially effective method for treating cancer, especially for tumors with high oncogenic KRAS4A expression. Here, HK1 is linked to cancer.